← Eichor
Study identifier: NCT05733832 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease

Condition: Liver Diseases  ·  Sponsor: Indiana University

PhaseNA
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.

This description comes directly from the study's public registry record.

Talk to the study team

Jake McCarty, BS  ·  317-278-6305  ·  jacmccar@iu.edu

Regina Weber, BS  ·  317-278-3584  ·  reginaw@iu.edu

Always discuss trial participation with your own doctor first.

Locations (4)

University of ChicagoChicago, Illinois, United StatesRecruiting
Indiana University Division of Gastroenterolgy and HepatologyIndianapolis, Indiana, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Albert Einstein Healthcare NetworkPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05733832